These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2314877)

  • 1. [Prothrombin and acarboxyprothrombin activity in neonates after oral and intramuscular administration of vitamin K].
    Goldschmidt B; Verbényi M; Kovács I; Ilin E; Varga K; Német T
    Orv Hetil; 1990 Mar; 131(11):577-82. PubMed ID: 2314877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of oral and intramuscular vitamin K on the factors II, VII, IX, X, and PIVKA II in the infant newborn under 60 days of age].
    Arteaga-Vizcaíno M; Espinoza Holguín M; Torres Guerra E; Diez-Ewald M; Quintero J; Vizcaíno G; Estévez J; Fernández N
    Rev Med Chil; 2001 Oct; 129(10):1121-9. PubMed ID: 11775338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of oral water soluble vitamin K on PIVKA-II levels in newborns.
    Sharma RK; Marwaha N; Kumar P; Narang A
    Indian Pediatr; 1995 Aug; 32(8):863-7. PubMed ID: 8635828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of milk intake and vitamin K supplementation to vitamin K status in newborns.
    Motohara K; Matsukane I; Endo F; Kiyota Y; Matsuda I
    Pediatrics; 1989 Jul; 84(1):90-3. PubMed ID: 2740181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Vitamin K 1 concentration and vitamin K-dependent clotting factors in newborn infants after intramuscular and oral administration of vitamin K 1].
    Goldschmidt B; Kisrákói C; Téglás E; Verbényi M; Kovács I
    Orv Hetil; 1990 Jun; 131(24):1297-300. PubMed ID: 2195426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acarboxyprothrombin concentration [corrected] after oral prophylactic vitamin K.
    von Kries R; Kreppel S; Becker A; Tangermann R; Göbel U
    Arch Dis Child; 1987 Sep; 62(9):938-40. PubMed ID: 3435609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Latent vitamin K deficiency in breast-fed infants].
    Goldschmidt B; Benedek L; Golán Z; Bukovszky M; Markó I
    Orv Hetil; 1990 Feb; 131(5):235-8. PubMed ID: 2406683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral and intramuscular vitamin K prophylaxis on PIVKA-II assay parameters in breastfed infants in Turkey.
    Uluşahin N; Arsan S; Ertogan F
    Turk J Pediatr; 1996; 38(3):295-300. PubMed ID: 8827897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries.
    van Hasselt PM; de Koning TJ; Kvist N; de Vries E; Lundin CR; Berger R; Kimpen JL; Houwen RH; Jorgensen MH; Verkade HJ;
    Pediatrics; 2008 Apr; 121(4):e857-63. PubMed ID: 18381514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of oral versus injectable vitamin K in neonates.
    Malik S; Udani RH; Bichile SK; Agrawal RM; Bahrainwala AT; Tilaye S
    Indian Pediatr; 1992 Jul; 29(7):857-9. PubMed ID: 1428134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin K prophylaxis in the neonates by oral route with different dosages.
    Pintadit P; Isarangkura PB; Chalermchandra K; Pongcharoen S; Sasanakul W; Chulajata R; Green GM
    J Med Assoc Thai; 1989 Jan; 72 Suppl 1():125-9. PubMed ID: 2732633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parenteral vitamin K1: the effective prophylaxis against haemorrhagic disease for all newborn infants.
    Clarkson PM; James AG
    N Z Med J; 1990 Mar; 103(885):95-6. PubMed ID: 2179775
    [No Abstract]   [Full Text] [Related]  

  • 13. A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants.
    Greer FR; Marshall SP; Severson RR; Smith DA; Shearer MJ; Pace DG; Joubert PH
    Arch Dis Child; 1998 Oct; 79(4):300-5. PubMed ID: 9875038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of subclinical vitamin K deficiency based on PIVKA-II levels: oral versus intramuscular route.
    Bakhshi S; Deorari AK; Roy S; Paul VK; Singh M
    Indian Pediatr; 1996 Dec; 33(12):1040-3. PubMed ID: 9141807
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of oral water soluble vitamin K in neonates.
    Sen S; Kumari S; Narayan S; Bains C; Dutta AK
    Indian Pediatr; 1989 Oct; 26(10):992-5. PubMed ID: 2630463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitamin K for newborn infants: why and how?].
    Maak B
    Kinderarztl Prax; 1993 Oct; 61(7-8):258-63. PubMed ID: 8271675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin K prophylaxis in the neonate by the oral route and its significance in reducing infant mortality and morbidity.
    Isarangkura PB; Bintadish P; Tejavej A; Siripoonya P; Chulajata R; Green GM; Chalermchandra K
    J Med Assoc Thai; 1986 Oct; 69 Suppl 2():56-61. PubMed ID: 3805949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K to neonates. Peroral versus intramuscular administration.
    Jørgensen FS; Felding P; Vinther S; Andersen GE
    Acta Paediatr Scand; 1991 Mar; 80(3):304-7. PubMed ID: 2035325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K prophylaxis for preterm infants: a randomized, controlled trial of 3 regimens.
    Clarke P; Mitchell SJ; Wynn R; Sundaram S; Speed V; Gardener E; Roeves D; Shearer MJ
    Pediatrics; 2006 Dec; 118(6):e1657-66. PubMed ID: 17101711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of various forms of vitamin-K prophylaxis in breastfed infants].
    Cornelissen EA; Monnens LA
    Ned Tijdschr Geneeskd; 1993 Oct; 137(43):2205-8. PubMed ID: 8247166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.